new_0222_0602|TCRR|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0602|TCRR|1|TCR2 Therapeutics Inc Total Current Assets (Quarterly) (USD)|TCR2 Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|TCR2 Therapeutics Inc Inventories (Quarterly) (USD)|TCR2 Therapeutics Inc Net PP&E (Quarterly) (USD)|TCR2 Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|TCR2 Therapeutics Inc Total Liabilities (Quarterly) (USD)|TCR2 Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|TCR2 Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|TCR2 Therapeutics Inc Total Deposits (Quarterly) (USD)|TCR2 Therapeutics Inc Book Value (Quarterly) (USD)|TCR2 Therapeutics Inc Retained Earnings (Quarterly) (USD)|TCR2 Therapeutics Inc Treasury Stock (Quarterly) (USD)|TCR2 Therapeutics Inc EV to Revenues|TCR2 Therapeutics Inc EV to Earnings|TCR2 Therapeutics Inc EV to Free Cash Flow|TCR2 Therapeutics Inc EV to Assets (Quarterly)|TCR2 Therapeutics Inc PS Ratio|TCR2 Therapeutics Inc PE Ratio|TCR2 Therapeutics Inc Price to Book Value|TCR2 Therapeutics Inc PEG Ratio|TCR2 Therapeutics Inc Debt to Equity Ratio|TCR2 Therapeutics Inc Dividend Yield|TCR2 Therapeutics Inc Shareholder Yield (TTM)|TCR2 Therapeutics Inc Percent of Shares Outstanding Short|TCR2 Therapeutics Inc Total Receivables (Quarterly) (USD)|TCR2 Therapeutics Inc Total Payables (Quarterly) (USD)|TCR2 Therapeutics Inc Total Capital Stock (Quarterly) (USD)|TCR2 Therapeutics Inc Return on Invested Capital|TCR2 Therapeutics Inc Quality Ratio Score|TCR2 Therapeutics Inc Momentum Score|TCR2 Therapeutics Inc Beta (1Y)|TCR2 Therapeutics Inc Sustainable Growth Rate (TTM)|TCR2 Therapeutics Inc Institutional Investor Ownership Percentage|TCR2 Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|TCR2 Therapeutics Inc Total Employees (Annual)|TCR2 Therapeutics Inc EPS Diluted (Quarterly) (USD)|TCR2 Therapeutics Inc SG&A Expense (Quarterly) (USD)|TCR2 Therapeutics Inc Shares Outstanding|TCR2 Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|TCR2 Therapeutics Inc Ordinary Shares Number (Quarterly)|TCR2 Therapeutics Inc Payout Ratio|TCR2 Therapeutics Inc Quick Ratio (Quarterly)|TCR2 Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|TCR2 Therapeutics Inc Stock Buybacks (Quarterly) (USD)|TCR2 Therapeutics Inc Effective Tax Rate (TTM)|TCR2 Therapeutics Inc Return on Equity|TCR2 Therapeutics Inc Net Income (TTM) (USD)|TCR2 Therapeutics Inc Revenue (TTM) (USD)|TCR2 Therapeutics Inc Dividend Per Share (Quarterly) (USD)|TCR2 Therapeutics Inc Revenue (Quarterly) (USD)|TCR2 Therapeutics Inc Gross Profit (Quarterly) (USD)|TCR2 Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|TCR2 Therapeutics Inc Net Income (Quarterly) (USD)|TCR2 Therapeutics Inc Net Interest Income (Quarterly) (USD)|TCR2 Therapeutics Inc Price (USD)|TCR2 Therapeutics Inc Total Return Price (USD)|TCR2 Therapeutics Inc Enterprise Value (USD)|TCR2 Therapeutics Inc 30-Day Average Daily Volume|TCR2 Therapeutics Inc 1 Year Price Returns (Daily)|TCR2 Therapeutics Inc Short Interest|TCR2 Therapeutics Inc PE Ratio (Forward)|TCR2 Therapeutics Inc PE Ratio (Forward 1y)|TCR2 Therapeutics Inc PS Ratio (Forward)|TCR2 Therapeutics Inc PS Ratio (Forward 1y)|TCR2 Therapeutics Inc Quarterly EPS Estimates (USD)|TCR2 Therapeutics Inc Quarterly Revenue Estimates (USD)|TCR2 Therapeutics Inc Quarterly EPS Surprise|TCR2 Therapeutics Inc Quarterly Revenue Surprise|TCR2 Therapeutics Inc Quarterly Actual EPS (USD)|TCR2 Therapeutics Inc Quarterly Actual Revenue (USD)|TCR2 Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|TCR2 Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|TCR2 Therapeutics Inc Price Target (USD)|TCR2 Therapeutics Inc Consensus Recommendation|TCR2 Therapeutics Inc Price Target Num Estimates|TCR2 Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|TCR2 Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|TCR2 Therapeutics Inc Research and Development Expense (Quarterly) (USD)|TCR2 Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|TCR2 Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|TCR2 Therapeutics Inc Land and Improvements (Quarterly) (USD)|TCR2 Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|TCR2 Therapeutics Inc Other Properties (Quarterly) (USD)|TCR2 Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0602|TCRR|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0602|TCRR|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|daily|daily|monthly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0602|TCRR|5|105.307692308|105.307692308||105.307692308||105.307692308|105.307692308|105.307692308||105.307692308|105.307692308||||6.96202531646||||6.98013245033|||1.44736842105||15.2253521127||105.307692308|105.307692308|||31.9523809524|30.5217391304|||91.2666666667|83.6666666667|91.2666666667|91.2666666667|32.4193548387||105.307692308|||91.2666666667|91.3571428571|91.2857142857||91.3333333333|||||91.2666666667|91.2666666667|91.3571428571|7.00636942675|7.00636942675|7.00636942675|6.96052631579|1.4468503937|15.2253521127||||1.44117647059|91.3333333333|91.3333333333|91.2857142857||91.2857142857|91.2857142857|35.3666666667|36.5862068966|22.829787234|10.4174757282|22.829787234|31.3529411765|35.5333333333|91.2666666667|91.2666666667||||105.307692308|105.307692308||
new_0222_0602|TCRR|6|13|13||13||13|13|13||13|13||||158||||151|||760||71||13|13|||21|23|||15|12|15|15|31||13|||15|14|7||12|||||15|15|14|157|157|157|152|508|71||||34|12|12|7||7|7|30|29|47|103|47|34|30|15|15||||13|13||
new_0222_0602|TCRR|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0602|TCRR|201712|20.703|19.811||1.026||48.363|1.231|47.132||-26.324|-26.324|||||||||||||||0.427||||||||15.0145||-0.302|1.29|||23.1899|||-0.2672|||||||||-4.012|-4.012|||||||||||||||||||||||||2.747|0.076||||1.312|0.105||
new_0222_0602|TCRR|201803||||||||||||||||||||||||||||||||||15.0145||-0.987|1.22||||||-0.2655|||||||||-3.986|-3.986|0.127||||||||||||||||||||||||2.893|0.076|||||||
new_0222_0602|TCRR|201806||||||||||||||||||||||||||||||||||15.0145||-1.1544|1.634||||||-0.4121|||||||||-6.187|-6.187|0.622||||||||||||||||||||||||5.175|0.112|||||||
new_0222_0602|TCRR|201809|131.39|130.998||1.791||4.204|3.792|0.412||130.464|-75.033|||||||||||||||1.509|0.002|||||||15.0145||-1.1974|1.704|||23.7922|||-0.4255||||-20.573|||||-6.388|-6.388|0.702||||||||||||||||||||||||5.386|0.115|||||||
new_0222_0602|TCRR|201812|125.493|123.167||1.638||215.129|5.465|209.664||-85.696|-85.59||||-19.7088|||||||||0.0768||2.663||||||||23.1899|47|-0.4925|2.222|23.9399||23.1899|||-0.3316||||-24.251|||||-7.69|-7.69|0.751|21.41|21.41|389.3863|||18384||||||||||||||||||6.219|0.116||||2.118|0.431||
new_0222_0602|TCRR|201903|165.585|161.656||1.936||5.812|5.357|0.455||192.047|-144.895||||-14.0622||||2.2424|||||0.4731||2.83|0.002|||||||12.3288|49|-4.85|2.886|23.7922||23.7922|||-4.85|-80.213|||-30.168|||||-9.903|-9.903|0.872|17.15|17.15|287.4023|88263.5667||113262|||||||||||||30.75|1.25|4|-1.545|-2.1|7.889|0.135||||2.398|0.431|16.98|14.6
new_0222_0602|TCRR|201906|175.677|169.626||3.172||7.624|7.16|0.464||182.636|-155.958||||-6.9182||||1.8287|||||0.7836||4.044|0.002|||||||23.818|57|-0.46|3.307|23.8567||23.8567|||-0.46||||-35.044|||||-11.063|-11.063|1.077|14.48|14.48|184.9952|35822.2667||187589|||||||||||||27.8|1.6|5|-3.25|-2.5|8.833|0.165||||3.902|0.431|13.67|16.86
new_0222_0602|TCRR|201909|166.617|161.005||4.463||8.357|7.883|0.474||171.154|-169.764||||-6.66||||2.1403|||||4.4521||3.621|0.002|||||||23.8746|72|-0.58|3.522|23.9441||23.9441|||-0.58|1.092|||-42.462|||||-13.806|-13.806|1.09|15.48|15.48|201.3739|179531.4667||1066005|||||||||||||25.5|1.6667|6|-3.29|-2.55|11.374|0.258||||4.93|0.431|13.39|16.95
new_0222_0602|TCRR|201912|163.185|158.124||4.926||8.079|7.533|0.546||160.449|-182.591||||-4.0746||||2.1343|||||4.0093||2.483|0.002||||0.924|||24.0389|83|-0.54|4.179|23.9811||23.9811|||-0.54|-0.011|-0.2148||-47.599|||||-12.725|-12.827|0.846|15.95|15.95|222.3373|106252.5667|-44.5119|961480|||||-0.58||22.569||-0.4491||||25.5|1.6667|6|-3.29||9.392|0.304||||5.717|0.501|14.68|11.88
new_0222_0602|TCRR|202003|132.957|126.116||5.22||6.712|6.129|0.583||146.592|-198.097||||-1.175||||1.2702|||||3.6376||3.179|0.002|||2|1.6615|||24.0118|88|-0.65|4.271|24.0565||24.0565|||-0.65||-0.2431||-53.202|||||-15.479|-15.506|0.747|6.74|6.74|4.1476|86352.2|-55.5938|875084|||||-0.53||-5.6981||-0.5602||||24.8333|1.6667|6|-2.26|-2.715|11.955|0.306||||6.243|0.537|10.75|11.71
new_0222_0602|TCRR|202006|133.777|124.813||5.957||6.969|6.36|0.609||133.413|-214.342||||-4.3091||||2.7752|||||3.7959||2.987|0.002|||4|2.3043|||24.076|94|-0.67|3.809|24.1046||24.1046|||-0.67||-0.2696||-58.384|||||-16.217|-16.245|0.499|15.36|15.36|245.4337|176824.9333|7.3375|914981|||||-0.585||-0.6838||-0.589||||33|1.6667|6|-2.385|-2.86|12.907|0.367||||7.327|0.633|16.28|19.36
new_0222_0602|TCRR|202009|254.232|246.723||6.201||8.487|7.852|0.635||252.363|-231.264||||-9.1366||||4.6312|||||6.3249||2.948|0.003|||7|2.2879|||30.3404|109|-0.56|4.371|33.3802||33.3802|||-0.56|-133.57|-0.3066||-61.5|||||-16.891|-16.922|0.3|19.35|19.35|520.3934|277491.7333|35.1963|2111278|||||-0.485||-0.9505||-0.4896||||35.5556|1.4444|9|-2.095|-2.285|12.82|0.441||||7.805|0.633|19.99|26.57
new_0222_0602|TCRR|202012|235.538|227.986||10.013||9.647|8.84|0.807||236.548|-249.715||||-13.3806||||4.0896|||||10.1361||2.448|0.003|||9|2.4533|||33.4881|118|-0.55|4.269|33.5168||33.5168|||-0.55|-0.001|-0.2404||-67.124|||||-18.376|-18.451|0.191|30.16|30.16|761.2875|588108.7333|116.5966|3397301|||||-0.485||0.4742||-0.4827|||4.5797|46.8889|1.4444|9|-2.095|-2.3|14.298|0.478||||8.566|0.541|27.21|26.57
new_0222_0602|TCRR|202103|342.971|333.281||51.842||46.424|10.521|35.903||349.755|-271.227||||-8.8935||||3.3664|||||13.319||3.83|0.004|||8|2.0165|||37.0626|131|-0.58|5.668|38.1592||38.1592|||-0.58|-131.33|-0.233||-73.13|||||-21.476|-21.512|0.116|20.88|20.88|568.3229|594680.9667|185.2713|5082438|||||-0.46||-7.8783||-0.4962||||45.6667|1.4444|9|-2.055|-2.51|15.924|0.513||||53.592|0.541|24.71|18.6
new_0222_0602|TCRR|202106|325.228|317.346||41.281||39.249|14.946|24.303||328.891|-295.539||||-4.3459||||1.8025|||||6.8351||4.819|0.004|||7|2.7551|||38.176|150|-0.64|5.666|38.1813||38.1813|||-0.64||-0.2383||-81.197|||||-24.261|-24.312|0.032|16.52|16.52|297.1635|310660.9|6.8359|2609729|||||-0.56||1.3357||-0.5525||||41.2222|1.4444|9|-2.4333|-2.9867|18.627|0.69||||43.572|0.541|12.62|16.77
new_0222_0602|TCRR|202109|303.219|295.741||41.684||40.454|16.52|23.934||306.27|-321.783||||-0.2039||||1.0092|||||4.6923||4.384|0.004|||3|4.4469|||38.1979|164|-0.69|5.963|38.2204||38.2204|||-0.69||-0.2259||-90.519|||||-26.202|-26.244|0.038|8.69|8.69|14.5798|920164.6|-58.1201|1793410|||||-0.61||1.0492||-0.6036||||31.8889|1.6667|9|-2.4067|-2.7967|20.277|0.773||||44.659|0.529|6.71|5.15
new_0222_0602|TCRR|202112|||||||||||||||1.4501||||0.5815|||||2.9636||||||1|2.8126||98.6992||||||||||||||||||||||4.66|4.66|-117.6339|869354.6667|-84.9337|1132717||||75.4097|-0.7033|||||||2.7555|20|1.9|9|-2.3133|-2.7875||||||||3.45|2.66
new_0222_0602|TCRR|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.62|||||||||||||||||||||
new_0222_0602|TCRR|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.61|||||||||||||||||||||
new_0222_0602|TCRR|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.515|||||||||||||||||||||
new_0222_0602|TCRR|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.53|||||||||||||||||||||